Timothy Kieffer

Chief Tech/Sci/R&D Officer at AARDVARK THERAPEUTICS, INC.

60 year

Health Technology

Consumer Services

Profile

Timothy Kieffer is Chief Scientific Officer at Aardvark Therapeutics, Inc. since 2025.
Formerly, Dr. Kieffer was Chief Scientific Officer at Fractyl Health, Inc., Chief Scientific Officer at ViaCyte, Inc. from 2021 to 2022, and Professor at the University of British Columbia.
Dr. Kieffer earned a doctorate from the University of British Columbia.

Timothy Kieffer active positions

Companies	Position	Start
AARDVARK THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2025-05-19

All active positions of Timothy Kieffer

Former positions of Timothy Kieffer

Companies	Position	End
ViaCyte, Inc. ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases	Chief Tech/Sci/R&D Officer	2022-09-30
University of British Columbia University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
FRACTYL HEALTH, INC.	Chief Tech/Sci/R&D Officer	-

See the detail of Timothy Kieffer's experience

Training of Timothy Kieffer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Timothy Kieffer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
ViaCyte, Inc. ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases	Health Technology
University of British Columbia University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fractyl Health, Inc. Fractyl Health, Inc. BiotechnologyHealth Technology Develops and sells therapeutics for metabolic diseases, type 2 diabetes & obesity	Health Technology
Aardvark Therapeutics, Inc. Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases	Health Technology